Researcher
Yohann Loriot
Persistent identifiers
References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.
Affiliation
PMNCO — Prédicteurs moléculaires et nouvelles cibles en oncologieRaMo-IT — Radiothérapie Moléculaire et Innovation Thérapeutique
Fields of expertise
Enzalutamide
atezolizumab
Urothelial carcinoma
cisplatin
urothelial cancer
Erdafitinib
Metastatic Urothelial Carcinoma
Docetaxel
8 publications in HAL since 2022.
Data provenance
Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.